Telehealth for Diabetes Self-Management
2 other identifiers
interventional
62
1 country
1
Brief Summary
This study will examine the feasibility and short and-long-term efficacy of a web-based telehealth intervention with community-dwelling older adults who have been diagnosed with type 2 diabetes. Effectiveness will be evaluated using multiple measures within three different domains: 1) physical (glycosylated hemoglobin \[HbA1C\], weight, and lipid levels); 2) behavioral (monitoring blood glucose levels, feet inspections, diet, and exercise frequency), and 3) psychosocial (depression, quality of life, social support, and adjustment to diabetes). This is a randomized controlled trial of a web-based telehealth intervention designed to improve self-management behaviors in a group of community dwelling older diabetics. Two groups of participants will be recruited and randomized over a four-month period during years 01 and 02. Participants in the control group will receive standard diabetic care provided by their provider. Participants in the intervention group will receive computer training in the participant's home in how to access and utilize the web-based telehealth study webpage. The intervention will consist of a program designed and delivered via the Internet to improve the participants' diabetes self-management behaviors using behavioral and motivational strategies and cues to modify perceptions of self-efficacy and beliefs regarding the ability to affect the progress of the disease and change personal behavior.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes
Started Sep 2003
Longer than P75 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 15, 2005
CompletedFirst Posted
Study publicly available on registry
September 19, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedNovember 14, 2007
November 1, 2007
September 15, 2005
November 13, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
glycosylated hemoglobin (A1C) levels.
one year
Secondary Outcomes (2)
Study participants who receive the web-based telehealth intervention will have fewer depression symptoms and higher quality of life, social support, at post-test (short-term) than participants in the control group.
1 year
Study participants who receive the web-based telehealth intervention will have fewer depression symptoms and higher quality of life, social support, at the 12 month (long-term) follow-up than participants in the control group.
one year
Study Arms (1)
1
EXPERIMENTALSubjects randomized into the treatment group received the computer treatment
Interventions
Eligibility Criteria
You may qualify if:
- diagnosed with Type 2 diabetes (American Diabetes Association criteria), i.e., fasting blood sugar levels of 126 mg/d or non-fasting levels of 200 mg/d when not taking glycemic control medication for diabetes
- diagnosed with diabetes for at least one year
- living in a non-institutional home in the community
- age 60 or older
- willing to be randomized
- able to read and write English or have an available caregiver or family member who can provide the necessary language translation.
You may not qualify if:
- moderate to severe cognitive impairment (less than 24 on the Mini Mental State Examination)
- severe vision impairment (greater than or equal to 9 on the Functional Vision Screening Scale);
- impairment of Activities of Daily Living (greater than 2 on Katz's Activities of Daily Living Scale);
- inability to hold and move objects; push buttons or use a trackball or a telephone;
- the presence of terminal debilitating medical conditions likely to result in death or severe disability prior to completion of the study;
- severe expressive or receptive communication impairment (inability to communicate will interfere with the administration of outcome measures), or
- no available phone-line or free electrical outlet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
University of Washington
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gail E Bond, Ph.D
University of Washington
- STUDY CHAIR
Fredric Wolf, Ph.D
University of Washington
- STUDY DIRECTOR
Martha Price, DNs
University of Washington
- STUDY CHAIR
Linda Teri, PhD
University of Washington
- STUDY CHAIR
Jerry Palmer
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 15, 2005
First Posted
September 19, 2005
Study Start
September 1, 2003
Study Completion
August 1, 2007
Last Updated
November 14, 2007
Record last verified: 2007-11